Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer

Treatment with (neo)adjuvant chemotherapy for breast cancer, as currently given, causes cell damage by induction of double-strand DNA breaks. Because BRCA1 and BRCA2 proteins play a role in the repair of DNA damage, the efficacy of (neo)adjuvant chemotherapy may be increased in BRCA1/2-associated br...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: Drooger, Jan C., Heemskerk-Gerritsen, Bernadette A. M., Smallenbroek, Nyrée, Epskamp, Cynthia, Seynaeve, Caroline M., Jager, Agnes
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2016
Témata:
Epidemiology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4837227/
https://ncbi.nlm.nih.gov/pubmed/27060914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3777-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky